Shalby Ltd. (SHALBY) Price & Analysis

Compare

0 Followers

SHALBY Stock Chart & Stats

₹202.80

-₹4.08(-1.73%)

At close: Jan 08 4:00 PM EST

₹202.80

-₹4.08(-1.73%)

Day’s Range― - ―

52-Week Range₹151.20 - ₹274.50

Previous CloseN/A

Volume74.36K

Average Volume (3M)71.31K

Market Cap

₹16.73B

Enterprise Value₹21.77B

Total Cash (Recent Filing)₹1.29B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)205.5

Beta1.20

Next Earnings

Jun 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.59%

Share Statistics

EPS (TTM)0.16

Shares Outstanding108,009,766

10 Day Avg. Volume22,132

30 Day Avg. Volume71,313

Financial Highlights & Ratios

PEG Ratio-3.76

Price to Book (P/B)2.18

Price to Sales (P/S)1.99

P/FCF Ratio-21.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.7

Revenue Forecast (FY)₹11.82B

Bulls Say, Bears Say

Bulls Say

Orthopaedic-focused Multi-specialty Hospital NetworkShalby's focused expertise in orthopaedics and joint replacement creates durable competitive differentiation: strong clinical reputation, referral flow, and procedure specialization support higher-case complexity and steady elective volumes. This specialization underpins predictable demand and pricing leverage over months.

Solid Equity Base (high Equity Ratio)A 58.2% equity ratio provides financial resilience and funding flexibility, enabling the firm to absorb operational shocks, pursue selective expansions, and limit near-term refinancing needs. This capital structure helps sustain operations during periods of margin stress.

Consistent Revenue Growth TrendSustained top-line growth indicates continued patient demand and successful capacity utilization. Over a 2-6 month horizon this supports longer-term recovery potential: growing revenues give management runway to improve margins and spread fixed costs as operations normalize.

Bears Say

Significant Margin CompressionLarge declines in gross and net margins signal lasting cost pressures or pricing weakness; narrower margins reduce internal cash generation and reinvestment capacity. Sustained margin erosion limits ability to fund capex, pay down debt, or restore ROE without structural cost or pricing fixes.

Negative Free Cash Flow And Weak Cash ConversionMaterial negative free cash flow and poor cash conversion are structural red flags: they constrain funding for maintenance and growth, increase reliance on external financing, and raise liquidity risk. Over months this can force prioritization of cash over strategic investments.

Rising Leverage And Falling ReturnsIncreased leverage combined with declining ROE elevates financial risk: interest obligations become more burdensome when profitability is thin, reducing buffer for downturns. This structural mix weakens capital efficiency and may limit strategic options without earnings recovery.

Shalby Ltd. News

Shalby Files SEBI Regulation 74(5) Compliance Certificate for December Quarter

An announcement from Shalby Ltd. ( ($IN:SHALBY) ) is now available. Shalby Limited has filed a confirmation certificate...

2M ago

Shalby Reports Nil Physical Share Transfer Re‑lodgement Requests for December 2025

The latest announcement is out from Shalby Ltd. ( ($IN:SHALBY) ). Shalby Limited has reported to the NSE...

2M ago

Shalby Limited Reports No Activity in Physical Share Transfers

Shalby Ltd. ( ($IN:SHALBY) ) has issued an announcement. Shalby Limited has submitted a report to the National...

4M ago

Shalby Hospitals Pioneers World’s First Autonomous Robotic Joint Surgery

Shalby Ltd. ( ($IN:SHALBY) ) just unveiled an announcement. Shalby Multi-Specialty Hospitals has achieved a significant milestone by...

7M ago

SHALBY FAQ

What was Shalby Ltd.’s price range in the past 12 months?

Shalby Ltd. lowest stock price was ₹151.20 and its highest was ₹274.50 in the past 12 months.

What is Shalby Ltd.’s market cap?

Shalby Ltd.’s market cap is ₹16.73B.

When is Shalby Ltd.’s upcoming earnings report date?

Shalby Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 94 days.

How were Shalby Ltd.’s earnings last quarter?

Shalby Ltd. released its earnings results on Feb 11, 2026. The company reported ₹0.164 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.164.

Is Shalby Ltd. overvalued?

According to Wall Street analysts Shalby Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shalby Ltd. pay dividends?

Shalby Ltd. pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.59%. See more information on Shalby Ltd. dividends here

What is Shalby Ltd.’s EPS estimate?

Shalby Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shalby Ltd. have?

Shalby Ltd. has 108,009,766 shares outstanding.

What happened to Shalby Ltd.’s price movement after its last earnings report?

Shalby Ltd. reported an EPS of ₹0.164 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.184%.

Which hedge fund is a major shareholder of Shalby Ltd.?

Currently, no hedge funds are holding shares in IN:SHALBY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shalby Ltd.

Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.